Medication Safety Intelligence

When a medicine is recalled, you deserve to know in minutes, not months.

Every year manufacturers withdraw batches of tablets, capsules, injectables and devices because of contamination, mislabelling, potency deviation or manufacturing defects. This service tracks enforcement reports, classifies each event by risk level, and explains — in plain language — exactly what a recall means for the medicine sitting in your cabinet right now.

Class I · II · III triage Lot & serial verification Plain-language guidance Free public alerts
Updated weekly
Prompt to generate image: ultra-realistic wide photograph of a pharmacy back-office with tall metal shelving organised by therapeutic class, one amber quarantine bin clearly labelled for recalled batches, cool clinical daylight, shallow depth of field, no people
Quarantine bin protocol · pharmacy back-office
Lot-level accuracy
What we do

Five layers of recall protection

A recall is only useful if it reaches the right person at the right moment. Our monitoring stack converts raw enforcement notices into verified, actionable instructions for patients, caregivers and dispensing teams.

Class I
01

Critical risk triage

Defect reports are sorted the moment they are published. We separate life-threatening events — defective sterile injectable syringes, undisclosed active ingredients, acute kidney injury risk — from routine corrections so urgent notices are never buried in a list.

Lot data
02

Lot & serial cross-checking

Enter the number printed beside the expiry date. The matching database compares it against every active and closed recall, then confirms whether your specific package, strength and manufacturer are inside or outside the affected range.

Reporting
03

Enforcement notice tracking

Public recall notices are mirrored within hours of publication. Each entry preserves the issuing authority, the classification code, the distribution scope and the remediation instruction — the four fields patients most often misread.

Interim
04

Interim safety guidance

Pending a full investigation, we publish interim advice: quarantine versus immediate disposal, whether a substitute therapy requires a new prescription, and which symptoms justify contacting a clinician without delay.

Follow-up
05

Closure verification

A recall is not finished when the box leaves the shelf. We track the termination audit, confirm the root cause, and flag whether a follow-up surveillance notice will follow once the manufacturer completes testing.

Education
06

Public education briefings

Monthly explainers translate regulatory language into household terms: what "expansion" of a recall means, why a hospital may hold stock that a pharmacy does not, and how to report a suspected adverse event correctly.

Prompt to generate image: extreme macro photograph of white pharmaceutical tablets and orange capsules arranged on a clean white surface with a magnifying glass resting beside them, crisp studio lighting, neutral background, no people
Identifying the exact tablet, strength and manufacturer before checking a lot number.
Practical workflow

What to do in the first ten minutes

  • Stop using the product and place the carton and tablets in a sealed bag.
  • Record the lot number, expiry date, strength and the manufacturer name exactly as printed.
  • Confirm whether the pharmacy that dispensed it has issued a matching quarantine notice.
  • Do not flush unused tablets; return them to a designated take-back point or pharmacy bin.
  • Contact a clinician before starting any replacement therapy, and keep the packaging for reference.
Reader feedback

Trusted by patients, pharmacists and caregivers

Verified accounts describe how quickly a lot check turned a confusing package into a clear decision — and how a single confirmed notice prevented an entire household from taking an unsafe dose.

Numbers behind the notices

Recall activity, quantified

The figures below aggregate public enforcement reporting over the last seven years. They illustrate how routine corrections dominate the volume, while a small minority of Class I events account for the majority of genuine patient harm.

0
Notices tracked
Public enforcement entries, 2019–2026
0
Resolved
Reaching a completed termination audit
0
Class I
Highest-risk events needing immediate action
0
Median alert
From publication to a searchable summary

Recall events by product category

Share of tracked enforcement notices

Annual recall volume

Notices published per year, 2019–2025

Classification Typical situation Share of notices Required action
Class I Contaminated injectable, undeclared active ingredient 11% Stop use immediately, return to pharmacy
Class II Potency outside specification, subpotent medicines 34% Quarantine pending advice from a clinician
Class III Labelling, packaging or documentation defects 55% Correct the label; therapy itself is not affected
Legal

Privacy policy

Legal

Site disclaimer

Contact

Report a recall, ask a question

Spotted a mismatched tablet, a damaged carton or a lot number that does not appear anywhere? Send the details and a member of the monitoring desk will verify the batch against active enforcement records and reply with guidance.

  • Include the exact lot or serial number, strength and manufacturer whenever possible.
  • Describe whether the product is still in its original packaging.
  • For suspected adverse events, contact your clinician first — this form is informational only.
  • We reply to every message that contains a checkable lot number.
Please enter your name.
Please enter a valid email address.
Please write at least 20 characters.
Your details are used only to answer this enquiry.
Newsletter control

Stop recall alerts

Enter the address that receives our medication recall bulletins. The request is recorded immediately and no further issue of the newsletter is transmitted to that mailbox.

Please enter a valid email address.
You can resubscribe at any time.